A phase I/II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer

被引：0
|
作者：
Kyoung Ha Kim
Young Suk Park
Myung Hee Chang
Hyo Song Kim
Hyun Jung Jun
Jieun Uhm
Seong Yoon Yi
Do Hyoung Lim
Sang Hoon Ji
Min Jae Park
Jeeyun Lee
Se Hoon Park
Joon Oh Park
Ho Yeong Lim
Won Ki Kang
机构：
[1] Samsung Medical Center,Division of Hematology
[2] Sungkyunkwan University School of Medicine,Oncology, Department of Medicine
来源：
Cancer Chemotherapy and Pharmacology | 2009年 / 64卷
关键词：
Docetaxel; Oxaliplatin; Advanced gastric cancer; Chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：347 / 353
页数：6
相关论文
共 50 条
  • [1] A phase I/II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer
    Kim, Kyoung Ha
    Park, Young Suk
    Chang, Myung Hee
    Kim, Hyo Song
    Jun, Hyun Jung
    Uhm, Jieun
    Yi, Seong Yoon
    Lim, Do Hyoung
    Ji, Sang Hoon
    Park, Min Jae
    Lee, Jeeyun
    Park, Se Hoon
    Park, Joon Oh
    Lim, Ho Yeong
    Kang, Won Ki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (02) : 347 - 353
  • [2] A phase I/II trial of docetaxel (D) and oxaliplatin (O) in patients with advanced gastric cancer (AGC)
    Park, Y.
    Kim, K.
    Choi, M.
    Hong, J.
    Lee, E.
    Park, M.
    Kim, H.
    Lee, Y.
    Park, J.
    Lim, H.
    Kang, W.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [3] Phase II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer and/or adenocarcinoma of the gastroesophageal junction
    Richards, D.
    McCollum, D.
    Wilfong, L.
    Sborov, M.
    Boehm, K. A.
    Zhan, F.
    Asmar, L.
    ANNALS OF ONCOLOGY, 2008, 19 (01) : 104 - 108
  • [4] Phase I/II docetaxel, oxaliplatin, and 5-fluorouracil combination chemotherapy in patients with advanced gastric cancer
    Kim, Sung Rok
    Park, Sung-En
    Yuh, Young Jin
    Sohn, Byeong Seok
    Lee, Hye Ran
    Song, Hong-Suk
    Lee, Kyung-Hee
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [5] Phase I trial of docetaxel, oxaliplatin, and capecitabine (DOC) in untreated gastric cancer patients
    Frustaci, Sergio
    Buonadonna, Angela
    Turchet, Elisa
    Corona, Giuseppe
    Tabaro, Gianna
    Miolo, GianMaria
    Torrisi, Elena
    Lo Re, Giovanni
    Tumolo, Salvatore
    Toffoli, Giuseppe
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2013, 18 (03) : 510 - 516
  • [6] Phase I trial of docetaxel, oxaliplatin, and capecitabine (DOC) in untreated gastric cancer patients
    Sergio Frustaci
    Angela Buonadonna
    Elisa Turchet
    Giuseppe Corona
    Gianna Tabaro
    GianMaria Miolo
    Elena Torrisi
    Giovanni Lo Re
    Salvatore Tumolo
    Giuseppe Toffoli
    International Journal of Clinical Oncology, 2013, 18 : 510 - 516
  • [7] Phase I/II trial of triplet regimen with docetaxel, oxaliplatin and capecitabine in advanced gastric and gastroesophageal cancers
    Eswaran, Prasad
    Kannan, Kalaichelvi
    Narasimhan, Srinivasan Lakshmi
    Kumar, Balaji Suresh
    Mavalavan, Dural
    CLINICAL CANCER INVESTIGATION JOURNAL, 2015, 4 (04): : 504 - 510
  • [8] Phase I/II trial with docetaxel and S-1 for patients with advanced or recurrent gastric cancer
    Zang, Dae Young
    Song, Hun Ho
    Kwon, Jung Hye
    Jung, Joo Young
    Kim, Hyo Jung
    Kim, Jung Han
    Shin, Hyen Chun
    Park, Young lee
    ANNALS OF ONCOLOGY, 2006, 17 : 314 - 314
  • [9] Phase I/II trial of gefitinib and oxaliplatin in patients with advanced colorectal cancer
    Kindler, HL
    Friberg, G
    Skoog, L
    Wade-Oliver, K
    Vokes, EE
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2005, 28 (04): : 340 - 344
  • [10] Phase I/II trial of docetaxel plus oxaliplatin and 5-fluorouracil (D-FOX) in patients with untreated, advanced gastric or gastroesophageal cancer
    Ajani, J. A.
    Phan, A.
    Ho, L.
    Tetzlaff, E. D.
    Baker, J.
    Wei, Q.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345